Fremont, United States
CliniOps, Inc, founded in 2013, is pioneering in the Life Science industry with its innovative platform for conducting Hybrid & Decentralized Clinical Trials (DCT). Positioned as the industry's first enterprise platform for this purpose, the company leverages cutting-edge technology to enable faster, more efficient, and inclusive drug trials.
Headquartered in the United States, CliniOps enhances the traditional clinical trial model by integrating Telemedicine capabilities, thus broadening the reach to participants and optimizing the process for Real World Evidence (RWE) and Patient Quality of Life (QoL) outcomes. This patient-centric approach supports their mission to make trials accessible and streamline data collection for improved outcomes.
Though details about recent investments are currently unavailable, CliniOps's technological edge and focus on decentralized trials make it a compelling candidate for stakeholders interested in the transformative potential of digital health innovations.
